Studies with (plus)--octanoylcarnitine in experimental diabetic ketoacidosis.
D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002208:Caproates / Q000378:metabolism; D002210:Caprylates / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002331:Carnitine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use* / Q000031:analogs & derivatives; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000188:drug therapy*; D004952:Esters / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D006461:Hemolysis / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007328:Insulin / Q000627:therapeutic use; D007657:Ketone Bodies / Q000096:biosynthesis; D008099:Liver / Q000378:metabolism; D008297:Male; D013268:Stimulation, Chemical
D001786:Blood Glucose; D002208:Caproates; D002210:Caprylates; D004952:Esters; D007328:Insulin; D007657:Ketone Bodies; C008698:octanoylcarnitine; D002331:Carnitine